Abstract:Current in-vitro 2D cultures and animal models present severe limitations in recapitulating human physiopathology with striking discrepancies in estimating drug efficacy and side effects when compared to human trials. For these reasons, microphysiological systems, organ-on-chip and multiorgans microdevices attracted considerable attention as novel tools for high-throughput and high-content research to achieve an improved understanding of diseases and to accelerate the drug development process towards more precise and eventually personalized standards. This review takes the form of a guide on this fast-growing field, providing useful introduction to major themes and indications for further readings. We start analyzing Organs-on-chips (OOC) technologies for testing the major drug administration routes: (1) oral/rectal route by intestine-on-a-chip, (2) inhalation by lung-on-a-chip, (3) transdermal by skin-on-a-chip and (4) intravenous through vascularization models, considering how drugs penetrate in the bloodstream and are conveyed to their targets. Then, we focus on OOC models for (other) specific organs and diseases: (1) neurodegenerative diseases with brain models and blood brain barriers, (2) tumor models including their vascularization, organoids/spheroids, engineering and screening of antitumor drugs, (3) liver/kidney on chips and multiorgan models for gastrointestinal diseases and metabolic assessment of drugs and (4) biomechanical systems recapitulating heart, muscles and bones structures and related diseases. Successively, we discuss technologies and materials for organ on chips, analyzing (1) microfluidic tools for organs-on-chips, (2) sensor integration for real-time monitoring, (3) materials and (4) cell lines for organs on chips. (Nano)delivery approaches for therapeutics and their on chip assessment are also described. Finally, we conclude with a critical discussion on current significance/relevance, trends, limitations, challenges and future prospects in terms of revolutionary impact on biomedical research, preclinical models and drug development.

The Role of Silicon Technology in Organ‐On‐Chip: Current Status and Future Perspective

A Comprehensive Review of Organ-on-a-Chip Technology and Its Applications

Advances in Organ-on-a-Chip Materials and Devices

Organ-On-a-Chip devices: Technology Progress and Challenges

1H NMR structural and functional characterisation of a cAMP-specific phosphodiesterase-4D5 (PDE4D5) N-terminal region peptide that disrupts PDE4D5 interaction with the signalling scaffold proteins, beta-arrestin and RACK1.

Silicon micro- and nanofabrication for medicine

Organ-on-a-Chip: Ubi sumus? Fundamentals and Design Aspects

A Comprehensive Review of Organ-on-Chip/Body-on-Chip Systems: Engineering, Applications, and Potential Impact on Drug Development and Administration

Organs-on-chips technologies - A guide from disease models to opportunities for drug development

Organ-on-a-chip: A new tool for in vitro research

An organ-on-chip device with integrated charge sensors and recording microelectrodes

Biomedical Application of Functional Materials in Organ-on-a-Chip

Organ-on-a-chip platforms for accelerating the evaluation of nanomedicine

Organoid-on-a-chip: Current challenges, trends, and future scope toward medicine

From Organ-on-a-Chip to Human-on-a-Chip: A Review of Research Progress and Latest Applications

Towards single-cell bioprinting: micropatterning tools for organ-on-chip development

Integrating organoids and organ-on-a-chip devices

Organ-on-a-chip platforms integrated with biosensors for precise monitoring of the cells and cellular microenvironment

Biosensors integrated 3D organoid/organ-on-a-chip system: A real-time biomechanical, biophysical, and biochemical monitoring and characterization

Advances in Spheroids and Organoids on a Chip

Organoids‐On‐a‐Chip for Personalized Precision Medicine